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Abstract
Xeroderma pigmentosum group A (XPA) is a hereditary dermatological disease in
which hypersensitivity to ultraviolet radiation and various neurological symptoms
are observed. In this study, to evaluate the degeneration occurring in the brain of
XPA patients, neurological examinations by an established neurologist and 3-Tesla
magnetic resonance imaging (MRI) were performed in 10 Japanese XPA patients.
MRIstudiesincludeddiffusiontensorimaging(DTI)andmagneticresonancespec-
troscopy (MRS) in addition to conventional sequences. Neurological examinations
revealedvariousdeteriorationsinthebothcentralandperipheralnervoussystemsin
all subjects. MRI studies demonstrated age-dependent decline in multimodalities.
Severe brain atrophy in conventional sequences, decreased fractional anisotropy
(FA) value in DTI, and reduced NAA/Cre ratio in MRS were observed in the adult
patients. Multimodal MRI studies unmask the neurological deterioration in XPA
patients.
Introduction
Xeroderma pigmentosum (XP) is a congenital autosomal re-
cessive disease in which photosensitivity and skin cancer due
tosunexposureareobserved.Eightcomplementationgroups
have been described in XP. Groups A–G (XPA–XPG) show
defectsinnucleotideexcisionrepairofdeoxyribonucleicacid
(DNA), while the XP variant (XPV) shows a defect in repli-
cation of DNA templates carrying unrepaired DNA damage.
In XPA, various neurological symptoms are observed apart
fromdermatologicalproblems(Mimakietal.1986).Inrecent
years,theremarkableprogressesinavoidanceofsunexposure
andintreatmentforskincancerhavemarkedlyimprovedthe
life expectancy of XPA, thereby the neurological disorders
have emerged as the critical factors that affect daily life and
disease prognosis (Anttinen et al. 2008).
Relentless progression of neurological deterioration con-
tinues even in XPA patients who avoid sun exposure. Al-
though atypical cases with mild neurological complications
havebeenreported(Robbinsetal.1991;Anttinenetal.2008),
the most of XPA patients follow a similar clinical course in
which they gradually deteriorate from having neurological
symptoms in childhood to being bedridden in adulthood
(Robbins et al. 1991). The pathogenesis of neuronal injury
in XPA is still unclear and there are no treatments available.
Pathologicalstudiesonautopsybrainwereperformedinafew
XPApatientswhoreachedadulthood(Kandaetal.1990;Itoh
et al. 1999), and revealed extensive loss of neurons and glio-
sis of the white matter in the central nervous system (CNS).
OnlyfewstudiesevaluatedCNSinvolvementofXPApatients
using head computed tomography, electroencephalography,
or cognitive function testing (Mimaki et al. 1989; Robbins
et al. 1991; Anttinen et al. 2008). There have been no reports
on detailed magnetic resonance imaging (MRI) analysis of
pediatric XPA patients.
In this preliminary study, we analyzed brain disorders in
XPA patients using several MRI sequences.
Subjects and Methods
Ten genetically proven Japanese XPA patients were studied
(Table 1). All patients had history of severe sunburn at the
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Table 1. Neurological examinations and 3-Tesla MRI results in 10 Japanese XPA patients
Patient no. Sex Age DTRs Babinski’s sign Ataxia Rigidity Hearing loss ADL
1M 1 d i m . e x t . −− − Stand holding on to something
2M 1 d i m . ﬂ e x . −− − Swaying walk
3M 6 d i m . e x t . +− + Walk unaided
4F 6 d i m . e x t . +− + Walk unaided
5 M 7 abs. ext. +− + Walk unaided
6F 8 d i m . e x t . +− − walk unaided
7 F 8 abs. ext. +− + Walk unaided
8 F 9 abs. ext. +− − Walk unaided
9 M 18 abs. ext. ++ + Wheelchair
10 F 20 abs. ind. −+ + Bedridden
M = male, F = female, DTRs = deep tendon reﬂexes (dim. = diminished, abs. = absent), Babinski’s sign = abnormal plantar reﬂex (ext. = extensor,
ﬂex. = ﬂexor, ind. = indifferent), ADL = activity of daily living. In ataxia, rigidity, and hearing loss, “+” means present and “−” means absent.
ﬁrst sun exposure after birth and were diagnosed on the ba-
sis of the clinical episode and measurement of the minimal
erythema dose. Most patients, except for No.7 and No.10,
weregeneticallydeterminedashavingmutationc.390–1G>C
in XPA by polymerase chain reaction restriction fragment
length polymorphism using restriction enzyme AlwNI ac-
cording to a previously described method (Nishigori et al.
1994). Each patient underwent neurological examination by
an established neurologist and imaging studies on the same
day. Images were obtained using a whole-body 3-Tesla MRI
system (Phillips Medical Systems, Eindhoven, The Nether-
lands).
At ﬁrst, we performed conventional sequences including
T1-weighted images (T1WI) (echo time (TE) = 3.3 msec,
repetitiontime(TR)=7.2msec,ﬂipangle=8◦,ﬁeldofview
(FOV) = 256 × 256 mm2,m a t r i x= 512 × 512, slice thick-
ness (ST) = 0.8 mm), T2-weighted images (T2WI) (TE =
120 msec, TR = 3500 msec, ﬂip angle = 90◦,F O V= 230 ×
230 mm2,m a t r i x= 512 × 512, ST = 5.0 mm), and
ﬂuid-attenuated inversion recovery (FLAIR) imaging (TE =
125 msec, TR = 11000 msec, ﬂip angle = 90◦,F O V= 230 ×
230 mm2,m a t r i x= 512 × 512, ST = 5.0 mm).
Next,weperformeddiffusiontensorimaging(DTI)(TE=
80 msec, TR = 8052 msec, ﬂip angle = 90◦,F O V= 256 ×
256 mm2,m a t r i x= 128 × 128, ST = 2.0 mm, motion
probing gradient = 15 directions, b-value = 1000) and
created fractional anisotropy (FA) maps using DTI Studio
software (http://cmrm.med.jhmi.edu/). Regions of interest
(ROI) were set in four locations on the basis of the DTI color
map atlas (Wakana et al. 2004) (Fig.1): the middle cerebellar
peduncle(MCP,30voxels;bilateral15voxelseach),posterior
limb of the internal capsule (PLIC, 14 voxels; bilateral seven
voxels each), corpus callosum (CC, 40 voxels; splenium and
genu 20 voxels each), and white matter of the parietal lobe
(WMP,30voxels;bilateral15voxels).WecalculatedmeanFA
values of 10 times settings in each location except when the
standard deviation was higher than 0.1.
Figure 1. Regions of interest (ROI) on the fractional anisotropy (FA)
color map are shown. MCP = middle cerebellar peduncle, gCC = genu
of corpuscallosum, sCC= splenium of corpuscallosum, PLIC = posterior
limb of the internal capsule, WMP = white matter of the parietal lobe.
In addition, we performed multivoxel magnetic resonance
spectroscopy (MRS) (TE = 144 msec, TR = 2000 msec,
FOV = 80 × 80 mm2, voxel of interest (VOI) size = 65 ×
65 mm2,m a t r i x= 16 × 16, ST = 15 mm, voxel resolu-
tion=5×5×15mm3). Multivoxelsweresetonthesection
containinggyruscinguliandcentrumsemiovale(frontopari-
etal white matter site) along with a reference (Doelken et al.
2009). As the parameter, N-acetyl aspartate (NAA), creatine
(Cre), choline (Cho), lactate, and lipid were analyzed. We
chose six voxels (three voxels on each side) in gyrus cin-
guli and centrum semiovale as ROI and calculated the mean
NAA/Cre ratio and the mean Cho/Cre ratio in these regions
(Fig. 2).
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Figure 2. In magnetic resonance spectroscopy (MRS) study, six voxels
(three voxels on each side) in centrum semiovale (A = white boxes) and
gyrus cinguli (B = white boxes) as region of interest. Spectrum of NAA,
creatine, or choline is shown (C).
InaccordancewiththeethicalguidelinesoftheDeclaration
of Helsinki, written informed consent was obtained from all
participants’ guardians under protocols approved by the In-
stitutionalReviewBoardofKobeUniversityGraduateSchool
of Medicine, Kobe, Japan.
Results
Neurological examinations
Patient proﬁles and neurological ﬁndings are summarized
in Table 1. Hearing loss is a common symptom in XP. Pro-
gressive intellectual deterioration disturbed accurate evalua-
tion for sensation. Deep tendon reﬂexes (DTRs) were absent
or diminished in all patients, and abnormal plantar reﬂex
(Babinski sign) were positive in eight of 10 patients. Those
neurological ﬁndings indicated that both upper and lower
motorneuroninvolvementstartedfromanearlystage.Cere-
bellarataxiawasobviousafter6yearsofage.Inan18-year-old
patient, an extrapyramidal sign was observed in association
with various neurological abnormalities. In patient No.10,
severe contractures in all extremities resulted in impossible
proper examination for the presence of ataxia or abnormal
reﬂexes.
Conventional MRI sequences
T1WIshowedthatdiffusebrainatrophywassevereinelderly
XPA patients (Fig. 3). T2WI and FLAIR imaging showed no
abnormalitysuchasvasculardiseaseormetaldepositsinany
patient. The arterial ﬂow void was also intact (ﬁgures not
shown).
Diffusion tensor imaging (DTI)
We calculated mean FA values and plotted the results against
the age of patients (Fig. 4). For most XPA patients between 6
and 9 years of age, FA values at any region differed little from
those in the 1-year-old patient. Furthermore, FA values were
lower in patients No.9 and No.10 compared with younger
patients, especially in the CC and WMP.
Magnetic resonance spectroscopy (MRS)
Peaks for lactate and lipid were not detected in any patient.
The NAA/Cre ratios were plotted against the patients’ age
shown in Figure 5. The NAA/Cre ratios ranged from 1.5 to
2.5 for patients No.1 through No.8 but fell below 1.5 for
patients No.9 and No.10. Cho/Cre ratios had no differences
between all patients (data not shown).
Discussion
The molecular mechanism for neuronal damage in XPA is
yet to be elucidated. Recently, it has been discussed that ac-
quired factors such as oxidative stress or excitatory amino
acid toxicity are related to CNS disorders in XPA. It was
reported that metabolic products of oxidative stress were ex-
hibitedinthebasalgangliainthebrainofXPApatients,while
apoptosis, neuroﬁbrillary tangles, or senile plaques were not
noted (Hayashi et al. 2005). Due to the inability to repair
DNA in XPA patients, acquired damage could be a factor in
theneurodegenerativechanges.DNAdamagefromoxidative
stress,however,iscommonlycorrectedby“base”excisionre-
pair (Robertson et al. 2009). Oppositely, XPA is a disorder of
“nucleotide” excision repair system. Unknown mechanism,
other than malfunction in DNA repair, is assumed to play an
important role in neuronal damage in XPA.
Neurological symptoms are common in XPA patients,
though its precise mechanism remains still unclear. The
onset of neurological symptoms in XPA seems to occur
between 3 and 8 years of age (Anttinen et al. 2008). In our
study,however,even1-year-oldpatientsshowedneurological
abnormalities such as a decline of DTRs. Some patients had
historyofseveralmonthsdelayofinitialwalking.Contraryto
general understanding, careful observation can detect neu-
rological symptoms in infancy in XPA patients.
Conventional MRI sequences showed brain atrophy and
expansion of frontal sinuses in adolescent patients. Every
region of the brain, including cortex, brain stem, and cere-
bellum, remarkably reduced in size in adult patients. There
was no diagnostic focal atrophy, such as spinocerebellar at-
rophy or corticobasal degeneration. Both white matter and
gray matter were reduced similar in severity.
In order to detect the structural change in white matter,
we measured FA values in several regions of the brain in XPA
using DTI. In normal children, the FA values of the brain
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Figure 3. Three axial views and one sagittal view from T1-weighted MRI images in (A) 1-year-old, (B) 9-year-old, and (C) 18-year-old XPA patients.
Figure 4. FA values in XPA patients are plotted against the age of patients.
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Figure 5. NAA/Cre ratios in the centrum semiovale (open circles) and
gyrus cinguli (ﬁlled circles) in XPA patients are plotted against the age of
patients.
increasesuntil2or3yearsofageandremainedapproximately
constantthereafter(Hermoyeetal.2006).Otherreportedthat
FA values were almost the same from 5 to 20 years of age in
normal controls (Schneider et al. 2004). After that, FA values
tended to gradually decline after 20 years of age (Moseley
2002). In our study, FA values were almost the same in any
age in child XPA patients, and were appeared to decline in
adolescent patients. Lack of increase in FA in infancy might
indicate that some damages of the CNS start very early in the
lifeofXPApatients.ThoseearlyreductionsinFAinthebrain
of XPA are consistent with those in other congenital devel-
opmental disorders such as Prader–Willi syndrome (Yamada
et al. 2006) or autism spectrum disorder (Shukla et al. 2011).
Furthermore,weusedMRStoassessmetabolicfunctionof
thebrainofXPApatients.Intheadultpatients(No.9andNo.
10), the NAA/Cre ratio was lower in both the cerebral cor-
tex (gyrus cinguli) and white matter (frontoparietal region)
thanthoseintheotherchildpatients.ReductioninNAA/Cre
representsnonspeciﬁcneuronaldamage.Wedidnotﬁndany
speciﬁc metabolic abnormalities in the brain of XPA.
Inourstudy,delicateneurologicalexaminationandmulti-
modal MRI studies unmask the onset of neurological deteri-
oration in XPA patients in early stage. Further accumulative
and longitudinal studies are needed.
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